Provided by Tiger Trade Technology Pte. Ltd.

Arvinas Holding Company LLC

7.74
+0.23503.13%
Pre-market: 7.740.00000.00%08:19 EDT
Volume:1.06M
Turnover:8.25M
Market Cap:505.76M
PE:57.86
High:8.04
Open:7.55
Low:7.44
Close:7.50
52wk High:14.51
52wk Low:6.97
Shares:65.39M
Float Shares:56.67M
Volume Ratio:1.43
T/O Rate:1.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1337
EPS(LYR):-1.1400
ROE:1.59%
ROA:-1.01%
PB:0.90
PE(LYR):-6.79

Loading ...

Iovance Biotherapeutics Names Noah Berkowitz Chief Medical Officer

Reuters
·
2 hours ago

Arvinas Grants New Hire Stock Option for 64,766 Shares, 42,388 RSUs Under NASDAQ Inducement Rule

Reuters
·
Yesterday

Arvinas Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Yesterday

Arvinas Doses First Patient in Phase 1/2 Trial of HPK1 Degrader ARV-6723 in Advanced Solid Tumors

Reuters
·
Sep 28

Arvinas Announces First Patient Dosed in Phase 1/2 Clinical Trial of Arv-6723, the Company’s First Immuno-Oncology Candidate

THOMSON REUTERS
·
Sep 28

Arvinas Grants 45,696 RSUs to Newly Hired Employee Under NASDAQ Inducement Award Plan

Reuters
·
Sep 02

Arvinas Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 02

Arcus Biosciences' Casdatifan Therapy Could be Launched in 2028, Morgan Stanley Says

MT Newswires Live
·
Aug 11

Arvinas Price Target Cut to $21.00/Share from $24.00 by Citigroup

Dow Jones
·
Aug 10

Citi Reaffirms Their Buy Rating on Arvinas Holding Company (ARVN)

TIPRANKS
·
Aug 10

Morgan Stanley Adjusts Price Target on Arvinas to $10 From $11, Maintains Equalweight Rating

MT Newswires Live
·
Aug 10

Arvinas Posts Corporate Presentation Highlighting Protac Degrader Pipeline in Oncology and Neurology

Reuters
·
Aug 07

Arvinas Launches New Cancer Combo Trial, Adding Fresh Optionality to ARVN

TIPRANKS
·
Aug 07

Analysts Offer Insights on Healthcare Companies: Exagen (XGN), Amgen (AMGN) and Arvinas Holding Company (ARVN)

TIPRANKS
·
Aug 05

Arvinas, Inc. : Wells Fargo Cuts to Equal Weight from Overweight

THOMSON REUTERS
·
Aug 05

Arvinas Holding Company (ARVN) Gets a Buy from Barclays

TIPRANKS
·
Aug 05

Wells downgrades Arvinas to Equal Weight, sees catalysts coming in 2027

TIPRANKS
·
Aug 05

Wedbush Adjusts Price Target on Arvinas to $12 From $11, Maintains Neutral Rating

MT Newswires Live
·
Aug 04

Arvinas Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Arvinas Q2 Operating Income USD 164.1 Million

Reuters
·
Aug 04